Boyd Eugene Haley (born September 22, 1940, Greensburg, Indiana) is an American anti-vaccine activist and retired professor of chemistry at the University of Kentucky.
[5] In 1992, Haley and a colleague, upon examining cerebrospinal fluid, reported levels of glutamine synthetase considerably higher in cases of Alzheimer's disease than in a control group, and suggested that this could be a biomarker to aid diagnosis.
[12] In 2008 a judge ruled that his "lack of expertise in genetics, epidemiology, and child neurology make it impossible for him to supply the necessary factual basis to support his testimony".
CTI marketed a product, OSR#1, for human consumption; it was described as an "antioxidant" dietary supplement that is a powerful chelator from a family originally developed to remove heavy metals from soil and acid mine drainage.
[15] In June 2008, an FDA toxicologist questioned[16] "on what basis the product could be expected to be safe and could be considered a dietary ingredient", but CTI Science and Haley had not responded as of January 2010.